Evidence map›Paper›PMID 27931559›Full record

ReviewIndian heart journal

Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart.

Vimal Agrawal, Jeetendra Kumar Gupta, Shaiba Sana Qureshi, Vishal Kumar Vishwakarma

Open access · goldAbstract readReview
In one paragraph

Review in Indian heart journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. ATPflugers Archiv : European journal of physiology · 2025
    Article
  3. Cardioprotective Role of Captopril: From Basic to Applied Investigations.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Frontiers in physiology · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vimal AgrawalInstitute of Pharmaceutical Research, GLA University, Mathura, UP, India.
Jeetendra Kumar GuptaInstitute of Pharmaceutical Research, GLA University, Mathura, UP, India. Electronic address: jkgupta81@rediffmail.com.
Shaiba Sana QureshiInstitute of Pharmaceutical Research, GLA University, Mathura, UP, India.
Vishal Kumar VishwakarmaInstitute of Pharmaceutical Research, GLA University, Mathura, UP, India.
GLA University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardio-vascular diseases are the leading cause of morbidity and mortality. Ischemia is a state of oxygen deprivation in tissues, whereas reperfusion is restoration of blood flow in ischemic tissues. Myocardial damage of tissue during reperfusion after ischemic insult is known as myocardial ischemia-reperfusion (I/R) injury. It induces damage to cardiac muscle via increasing expression of oxygen, sodium and calcium ions which are responsible in the activation of proteases and cell death. Heart renin angiotensin system (RAS) plays an important role in the myocardial ischemia and reperfusion injury. Angiotensin (1-7) is responsible for vasodilation and angiotensin II for vasoconstriction. Here-in we reviewed how myocardial I/R injury sets in by up-regulation of angiotensin II that leads to increased infarct size, which can be reduced by the use of ACE inhibitors, ACE2 activators and angiotensin II antagonist.

Indexed as

AnimalsHumansIschemic Preconditioning, MyocardialMyocardial Reperfusion InjuryMyocardiumRenin-Angiotensin SystemACE2 activatorACE inhibitorAngiotensin II antagonistIschemia preconditioningMyocardial ischemia–reperfusion injury

Identifiers

PMID27931559
PMCPMC5143827
OpenAlexW2508057623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.